Table 5.
Breast cancer data: estimated coefficients and standard errors (in parentheses) in the correlated subhazard frailty model for a type 1 event
Variable | No-penalty | LASSO | SCAD | HL |
---|---|---|---|---|
x1: GROUP=tamoxifen | −0.617(0.107) | −0.528 (0.097) | −0.610(0.106) | −0.521 (0.097) |
x2: RACE1 | −0.202 (0.267) | 0 (0) | 0 (0) | 0 (0) |
x3: RACE2 | −0.165 (0.340) | 0 (0) | 0 (0) | 0 (0) |
x4: MENSE1 | 0.112(0.222) | 0 (0) | 0 (0) | 0 (0) |
x5: MENSE2 | −0.158(0.265) | 0 (0) | 0 (0) | 0 (0) |
x6: RNOD | −0.139(0.051) | −0.124 (0.046) | −0.139(0.050) | −0.109 (0.044) |
x7: TSIZE | 0.272 (0.041) | 0.254 (0.039) | 0.266 (0.040) | 0.253 (0.039) |
x8: ER | 0.077 (0.037) | 0.069 (0.035) | 0.022 (0.019) | 0.068 (0.032) |
x9: PR | 0.058 (0.045) | 0.052 (0.040) | 0 (0) | 0 (0) |
x10: SURGTYPE=mastectomy | −0.089(0.101) | 0 (0) | 0 (0) | 0 (0) |
HL, h-likelihood penalty function; GROUP, treatment group (placebo, tamoxifen); RACE, race (white, black, other); RACE1=I(RACE=white); RACE2=I(RACE=black); MENSE, menopausal status (premenopausal, perimenopausal, postmenopausal); MENSE1=I(MENSE=premenopausal); MENSE2=I(MENSE=perimenopausal); RNOD, number of nodes removed; TSIZE, tumor size (mm); ER, estrogen receptor level; PR, progesterone receptor level; SURGTYPE, surgery type (lumpectomy, mastectomy)